Skip to main content

Advertisement

Log in

Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Poon RT, Fan ST, Wong J, et al. Clinical implications of circulating angiogenic factor in cancer patients. J Clin Oncol 2001;19:1207–25.

    PubMed  CAS  Google Scholar 

  2. Gasparini G, Toi M, Gion M, et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 1997;89:139–47.

    Article  PubMed  CAS  Google Scholar 

  3. Vincenti V, Cassano C, Roschi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996;93:1493–95.

    PubMed  CAS  Google Scholar 

  4. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003;106:468–71.

    Article  PubMed  CAS  Google Scholar 

  5. Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 2006;15:1148–52.

    Article  PubMed  CAS  Google Scholar 

  6. Jin Q, Hemminki K, Enquist K, Lenner P, et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005;11:3647–53.

    Article  PubMed  CAS  Google Scholar 

  7. Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL, Patel AV, Thun MJ, Calle EE. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the cancer prevention study II cohort. Breast Cancer Res 2006;8:R22.

    Article  PubMed  Google Scholar 

  8. Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 2002;3:229–32.

    Article  PubMed  CAS  Google Scholar 

  9. Lee SJ, Lee SY, Jeon HS, et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2005;14:571–5.

    Article  PubMed  CAS  Google Scholar 

  10. Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L. Association of VEGF genetic polymorphism with prostate carcinoma risk and clinical outcome. Cytokine 2006;35:21–8.

    Article  PubMed  CAS  Google Scholar 

  11. Renner W, Kotschan S, Hoffman C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443–8.

    Article  PubMed  CAS  Google Scholar 

  12. Eroglu A, Gulec S, Kurtman C, Cam R, Akar N. Vascular endothelial growth factor 936 C/T polymorphism in cancer patients. Ann Oncol 2006;17:1467–68.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aydan Eroğlu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eroğlu, A., Öztürk, A., Çam, R. et al. Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients. Med Oncol 25, 54–55 (2008). https://doi.org/10.1007/s12032-007-0046-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-007-0046-4

Keywords

Navigation